Current therapeutics against HCV-Reference-Cited by-同舟云学术

Current therapeutics against HCV

Published:2021-06 Issue:2 Volume:32 Page:228-243
ISSN:2347-3584
Container-title:VirusDisease
language:en
Short-container-title:VirusDis.

Author:

Bhattacharjee Chayan,Singh Maitri,Das Debisukti,Chaudhuri Sujit,Mukhopadhyay Aparna^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Virology

Link

https://link.springer.com/content/pdf/10.1007/s13337-021-00697-0.pdf

Reference61 articles.

1. Alexopoulou A, Karayiannis P. Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals. Ann Gastroenterol. 2015;28(1):55–65.

2. Altmann SW, et al. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim Biophys Acta Mol Cell Biol Lipids. 2002;1580(1):77–93. https://doi.org/10.1016/S1388-1981(01)00190-1.

3. Bachmetov L, et al. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J Viral Hepat. 2012. https://doi.org/10.1111/j.1365-2893.2011.01507.x.

4. Bartenschlager R. Hepatitis C virus: from molecular virology to antiviral therapy. 1st ed, vol. 369. Heidelberg: Springer; 2013.

5. Black S, et al. P0891: resistance analysis of virologic failures in Hepatitis C genotype 1 infected patients treated with grazoprevir/elbasvir +/− ribavirin: the C-worthy study. J Hepatol. 2015;62(1):S677–8. https://doi.org/10.1016/s0168-8278(15)31094-1.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences;Pathogens;2024-08-09

2. The Rise of Bacterial G-Quadruplexes in Current Antimicrobial Discovery;ACS Omega;2024-05-30

3. Determination of hepatitis C virus subtype prevalent in Sindh, Pakistan: a phylogenetic analysis;Scientific Reports;2024-05-15

4. Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV);Viruses;2024-04-26

5. A Retrospective Study to Determine the Genotypic Distribution of Hepatitis-C from a Tertiary Care Hospital in South India;Journal of Pure and Applied Microbiology;2023-09-01